Stay updated on Elsubrutinib & Upadacitinib in SLE Clinical Trial
Sign up to get notified when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.

Latest updates to the Elsubrutinib & Upadacitinib in SLE Clinical Trial page
- Check5 days agoChange DetectedThe record history now shows a new revision tag v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page's revision history metadata.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s UI/version footer was updated from revision v3.5.2 to v3.5.3. This reflects a technical site update rather than any change to the underlying clinical trial record.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded revision entry v3.5.2 and removed revision v3.5.0 from the history.SummaryDifference0.1%

- Check62 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check76 days agoChange DetectedThe record history shows a new revision v3.4.3 added, replacing the previous v3.4.2.SummaryDifference0.1%

- Check98 days agoChange DetectedA new revision entry v3.4.2 was added and the previous v3.4.1 entry was removed, reflecting a minor maintenance update to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Elsubrutinib & Upadacitinib in SLE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.